Artigo Original
Miguel et al.
ITB e mortalidade em longo prazo na hemodiálise
Arq Bras Cardiol. 2017; 108(3):204-211
1. Foley RN, Parfrey PS, Sarnak M. Clinical epidemiology of cardiovascular
diseaseinchronicrenaldisease.AmJKidneyDis.1998;32(5Suppl.3):S112-9.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al.
Chronic kidney disease and mortality risk: a systematic review. J Am
Soc Nephrol 2006;17(7):2034-47.
3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic
uremia. J Am Soc Nephrol. 1999;10(7):1606-15.
4. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the
cardiovascular system. Circulation. 2007;116(1):85-97.
5. Fishbane S, Youn S, Kowalski EJ, Frei GL. Ankle-arm blood pressure index as
a marker for atherosclerotic vascular diseases in hemodialysis patients. Am J
Kidney Dis. 1995;25(1):34-9.
6. Rajagopalan S, Dellegrottaglie S, Furnis AL, Gillespie BW, Satayathum S,
Lameire N, et al. Peripheral arterial disease in patients with end-stage renal
disease:observationsfromtheDialysisOutcomesandPracticePatternsStudy
(DOPPS). Circulation. 2006; 114(18):1914-22.
7. FishbaneS,YounS,FlasterE,AdamG,Maesaka JK.Ankle-armbloodpressure
index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis.
1996;27(5):668-72.
8. OnoK,TsuchidaA,KawaiH,MatsuoH,WakamatsuR,MaezawaA,etal.Ankle-
brachial blood pressure index predicts all-cause and cardiovascular mortality in
hemodialysispatients.JAmSocNephrol.2003;14(6):1591-8.
9. Jimenez ZN, Pereira BJ, Romão JE Jr, Makida SC, Abensur H, Moyses RM, et
al. Ankle-brachial index: a simple way to predict mortality among patients on
hemodialysis--aprospectivestudy.PLoSOne.2012;7(7):e42290.
10. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in
epidemiologicalsurveys.IntJEpidemiol.1988;17(2):248-54.
11. DonnellyR,HinwoodD,LondonNJ.Noninvasivemethodsofarterialandvenous
assessment.BMJ.2000;320(7236):698-701.
12. NewmanAB,ShemanskiL,ManolioTA,CushmanM,MittelmarkM,Polak JF,et
al. Ankle-arm index as a predictor of cardiovascular disease andmortality in the
cardiovascularhealthstudy.TheCardiovascularHealthStudyGroup.Arterioscler
ThrombVascBiol.1999;19(3):538-45.
13. Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm
bloodpressureindexandmortalityinelderlywomen.JAMA.1993;270(4):465-9.
14. BarnhorstDA,BarnerHB.Prevalenceofcongenitallyabsentpedalpulses.NEngl
JMed.1968;278(5):264-5.
15. Newman AB, Sutton-Tyrel K, Vogt MT, Kuller LH. Morbidity and mortality
in hypertensive adults with a low ankle/arm blood pressure index. JAMA.
1993;270(4):487-9.
16. Miguel JB, Strogoff deMatos JP, Ruzany F, Miguel CS, Miguel SJ, Naveiro LT, et al.
Association of ankle-arm indexwith inflammation andmineral bone disorder in
hemodialysispatients.ArqBrasCardiol2011;96(5):405-9.
17. BrasileiroAC,OliveiraDC,VictorEG,OliveiraDA,BatistaLL.Associationbetween
ankle-brachial index and carotid atherosclerotic disease. Arq Bras Cardiol.
2013;100(5):422-8.
18. Albuquerque PF, Albuquerque PH, Albuquerque GO, Servantes DM, Carvalho
SM, Filho JA. Ankle-brachial index and ventricular hypertrophy in arterial
hypertension.ArqBrasCardiol.2012;98(1):84-6.
19. Chen SC, Chang JM, Hwang SJ, Tsai JC, LiuWC, Wang CS, et al. Ankle brachial
index as a predictor for mortality in patients with chronic kidney disease and
undergoinghemodialysis.Nephrology(Carlton).2010;15(3):294-9.
20. AdragaoT,PiresA,BrancoP,CastroR,OliveiraA,NogueiraC,etal.Ankle-brachial
index, vascular calcifications and mortality in dialysis patients. Nephrol Dial
Transplant.2012;27(1):318-25.
21. Kitahara T, Ono K, Tsuchida A, Kawai H, Shinohara M, Ishii Y, et al.
Impact of brachial-ankle pulse wave velocity and ankle-brachial blood
pressure index on mortality in hemodialysis patients. Am J Kidney Dis.
2005;46(4):688-96.
22. Otsubo S, Kitamura M, Wakaume T, Yajima A, Ishihara M, Takasaki M,
et al. Association of peripheral artery disease and long-term mortality in
hemodialysis patients. Int Urol Nephrol. 2012;44(2):569-73
23. KochM, HollenbeckM, Trapp R, KulasW, Grabensee B. Value of diabetes as
an independent predictor of death in subjects with end-stage renal disease.
Med Klin (Munich). 2006;101(12):933-7.
24. Ajiro J, Alchi B, Narita I, Omori K, Kondo D, Sakatsume M, et al. Mortality
predictors after 10 years of dialysis: a prospective study of Japanese
hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(4):653-60.
25. Kawaguchi T, Tong L, Robinson BM, Sen A, Fukuhara S, Kurokawa K, et al.
C-reactiveproteinandmortalityinhemodialysispatients:theDialysisOutcomes
andPracticePatternsStudy(DOPPS).NephronClinPract.2011;117(2):c167-78.
26. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al.
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.
Kidney Int. 2000;58(1):353-62.
27. O’Hare A, Hsu CY, Bacchetti P, Johansen K. Peripheral vascular disease
risk factors among patients undergoing hemodialysis. J Am Soc Nephrol.
2002;13(2):497-503.
28. RidkerPM,CushmanM,StampferMJ,TracyRP,HennekensCH.Inflammation,
aspirin, and the risk of cardiovascular disease in apparently healthy men. N
EnglJMed.1997;336(14):973-9.Erratum in:NEnglJMed1997;337(5):356.
29. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation
enhances cardiovascular risk andmortality in hemodialysis patients. Kidney
Int. 1999;55(2):648-58.
30. Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in
peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34(1):18-22.
31. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial
disease in the United States: results from the National Health and Nutrition
Examination Survey, 1999-2000. Circulation. 2004;110(6):738-43.
32. Vega A, Perez-García R, Abad S, Verde E, López-Gómez JM, Jofré R, et al.
[Peripheral vascular disease: prevalence, mortality and association with
inflammation in haemodialysis]. Nefrologia. 2008;28(3):311-6.
33. van Jaarsveld BC, van der Graaf Y, Vos PF, Soedamah-Muthu SS; Smart Study
Group. Quantifying exposure to calciumand phosphate in ESRD; predictive
of atherosclerosis on top of arteriosclerosis? Neth JMed. 2010;68(12):431-8.
34. Tsuchihashi K, Takizawa H, Torii T, Ikeda R, Nakahara N, Yuda S, et al.
Hypoparathyroidism potentiates cardiovascular complications through
disturbed calcium metabolism: possible risk of vitamin D(3) analog
administration in dialysis patients with end-stage renal disease. Nephron.
2000;84(1):13-20.
35. Lorenzo V, Martin M, Rufino M, Jiménez A, Malo AM, Sanchez E, et al.
Protein intake, control of serum phosphorus, and relatively low levels of
parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis.
2001;37(6):1260-6.
36. Gupta R. “Mid-term,” “long-term,” and other terms: making sense of clinical
follow-up. AJNR Am J Neuroradiol. 2008;29(1):6.
Referências
211
